Novavax (NVAX) Breaks Higher
December 2, 2009 · Filed Under flu
Novavax, Inc. (NASDAQ: NVAX) is trading up again on swine flu or H1N1 news. The company issued a press release showing positive clinical results from a pivotal study of H1N1 influenza vaccine in Mexico. It is up 7% to $3.43.
Douglas A. McIntyre



